Literature DB >> 12852693

Validity and representativity in the Danish Breast Cancer Cooperative Group--a study on protocol allocation and data validity from one county to a multi-centre database.

Anni R Jensen1, Hans H Storm, Susanne Møller, Jens Overgaard.   

Abstract

Population-based cancer registries collect basic information on incident cases, whereas clinical databases hold a broad range of variables that make them attractive sources in epidemiological research. Quality, completeness and representativeness of the clinical database in the Danish Breast Cancer Cooperative group (DBCG) were compared with those in a complete population-based database holding detailed information on patients with breast cancer. The study included 1765 patients diagnosed in Aarhus County between 1983 and 1989. Data on tumour characteristics were of high quality. Fifty percent of patients were included in DBCG trials and a total of 83% were notified in the DBCG register, the rest having significantly poorer stage distribution and survival probabilities. However, for patients younger than 70 years of age, the difference in overall survival between all patients and those notified in the DBCG register was only 2%. Follow-up was incomplete in patients treated outside the programme, and this had a major impact on recurrence-free survival. The DBCG database holds high-quality data, but as a population-based database, it is neither comprehensive nor representative.

Entities:  

Mesh:

Year:  2003        PMID: 12852693     DOI: 10.1080/02841860310000737

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  9 in total

1.  Representativeness of participants in the cancer care outcomes research and surveillance consortium relative to the surveillance, epidemiology, and end results program.

Authors:  Paul J Catalano; John Z Ayanian; Jane C Weeks; Katherine L Kahn; Mary Beth Landrum; Alan M Zaslavsky; Jeannette Lee; Jane Pendergast; David P Harrington
Journal:  Med Care       Date:  2013-02       Impact factor: 2.983

2.  Validation of an Algorithm to Ascertain Late Breast Cancer Recurrence Using Danish Medical Registries.

Authors:  Rikke Nørgaard Pedersen; Buket Öztürk; Lene Mellemkjær; Søren Friis; Trine Tramm; Mette Nørgaard; Deirdre P Cronin-Fenton
Journal:  Clin Epidemiol       Date:  2020-10-14       Impact factor: 4.790

3.  Risk of Parkinson's disease after tamoxifen treatment.

Authors:  Jeanne C Latourelle; Merete Dybdahl; Anita L Destefano; Richard H Myers; Timothy L Lash
Journal:  BMC Neurol       Date:  2010-04-12       Impact factor: 2.474

4.  Reliable PCR quantitation of estrogen, progesterone and ERBB2 receptor mRNA from formalin-fixed, paraffin-embedded tissue is independent of prior macro-dissection.

Authors:  Trine Tramm; Guido Hennig; Marianne Kyndi; Jan Alsner; Flemming Brandt Sørensen; Simen Myhre; Therese Sørlie; Jens Overgaard
Journal:  Virchows Arch       Date:  2013-10-08       Impact factor: 4.064

5.  Incidence of and survival from oligodendroglioma in Denmark, 1943-2002.

Authors:  Malene Schjønning Nielsen; Helle Collatz Christensen; Michael Kosteljanetz; Christoffer Johansen
Journal:  Neuro Oncol       Date:  2008-12-09       Impact factor: 12.300

6.  Low-dose Aspirin, Nonsteroidal Anti-inflammatory Drugs, Selective COX-2 Inhibitors and Breast Cancer Recurrence.

Authors:  Deirdre P Cronin-Fenton; Uffe Heide-Jørgensen; Thomas P Ahern; Timothy L Lash; Peer Christiansen; Bent Ejlertsen; Henrik T Sørensen
Journal:  Epidemiology       Date:  2016-07       Impact factor: 4.822

7.  Cohort Profile: the Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in Denmark.

Authors:  Lindsay J Collin; Deirdre P Cronin-Fenton; Thomas P Ahern; Peer M Christiansen; Per Damkier; Bent Ejlertsen; Stephen Hamilton-Dutoit; Anders Kjærsgaard; Rebecca A Silliman; Henrik Toft Sørensen; Timothy L Lash
Journal:  BMJ Open       Date:  2018-08-01       Impact factor: 2.692

8.  The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis.

Authors:  Rikke Nørgaard Pedersen; Buket Öztürk Esen; Lene Mellemkjær; Peer Christiansen; Bent Ejlertsen; Timothy Lee Lash; Mette Nørgaard; Deirdre Cronin-Fenton
Journal:  J Natl Cancer Inst       Date:  2022-03-08       Impact factor: 13.506

9.  Expressive writing intervention and self-reported physical health out-comes - Results from a nationwide randomized controlled trial with breast cancer patients.

Authors:  Mikael B Jensen-Johansen; Mia S O'Toole; Søren Christensen; Heiddis Valdimarsdottir; Sandra Zakowski; Dana H Bovbjerg; Anders B Jensen; Robert Zachariae
Journal:  PLoS One       Date:  2018-02-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.